287 related articles for article (PubMed ID: 22803671)
1. Synthesis and antileishmanial activity of novel pyridinium-hydrazone derivatives.
Alptuzun V; Cakiroglu G; Limoncu ME; Erac B; Hosgor-Limoncu M; Erciyas E
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):960-7. PubMed ID: 22803671
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 2-methoxybenzoylhydrazone and evaluation of their antileishmanial activity.
Taha M; Baharudin MS; Ismail NH; Khan KM; Jaafar FM; Samreen ; Siddiqui S; Choudhary MI
Bioorg Med Chem Lett; 2013 Jun; 23(11):3463-6. PubMed ID: 23608761
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives.
Foroumadi A; Emami S; Pournourmohammadi S; Kharazmi A; Shafiee A
Eur J Med Chem; 2005 Dec; 40(12):1346-50. PubMed ID: 16095763
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in-vitro leishmanicidal activity of hydrazones of thiophene carboxaldehydes against promastigotes of Leishmania infantum and Leishmania tropica.
Savornin B; Madadi NE; Delmas F; Gasquet M; Timon-David P; Vanelle P; Maldonado J
J Pharm Pharmacol; 1991 Jan; 43(1):58-9. PubMed ID: 1676064
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes.
Gómez-Pérez V; Manzano JI; García-Hernández R; Castanys S; Gamarro F; Campos JM
Eur J Med Chem; 2015 Jan; 89():362-9. PubMed ID: 25462252
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity.
Muhammad MT; Ghouri N; Khan KM; Arshia ; Choudhary MI; Perveen S
Med Chem; 2018; 14(7):725-732. PubMed ID: 29332596
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological activity, and mechanism of action of new 2-pyrimidinyl hydrazone and N-acylhydrazone derivatives, a potent and new classes of antileishmanial agents.
Coimbra ES; Nora de Souza MV; Terror MS; Pinheiro AC; da Trindade Granato J
Eur J Med Chem; 2019 Dec; 184():111742. PubMed ID: 31605866
[TBL] [Abstract][Full Text] [Related]
12. 7-Chloro-4-quinolinyl hydrazones: a promising and potent class of antileishmanial compounds.
Coimbra ES; Antinarelli LM; da Silva AD; Bispo ML; Kaiser CR; de Souza MV
Chem Biol Drug Des; 2013 May; 81(5):658-65. PubMed ID: 23350797
[TBL] [Abstract][Full Text] [Related]
13. Oxazolo[3,2-a]pyridine. A new structural scaffold for the reversal of multi-drug resistance in Leishmania.
Caballero E; Manzano JI; Puebla P; Castanys S; Gamarro F; San Feliciano A
Bioorg Med Chem Lett; 2012 Oct; 22(19):6272-5. PubMed ID: 22939695
[TBL] [Abstract][Full Text] [Related]
14. Benzimidazole derivatives endowed with potent antileishmanial activity.
Tonelli M; Gabriele E; Piazza F; Basilico N; Parapini S; Tasso B; Loddo R; Sparatore F; Sparatore A
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):210-226. PubMed ID: 29233048
[TBL] [Abstract][Full Text] [Related]
15. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A
Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243
[TBL] [Abstract][Full Text] [Related]
16. GRIND2-based 3D-QSAR and prediction of activity spectra for symmetrical bis-pyridinium salts with promastigote antileishmanial activity.
Diniz EMLP; Tomich de Paula da Silva CH; Gómez-Perez V; Federico LB; Campos Rosa JM
J Biomol Struct Dyn; 2017 Aug; 35(11):2430-2440. PubMed ID: 27495391
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR
J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790
[TBL] [Abstract][Full Text] [Related]
18. Novel coumarin-isatin hybrids as potent antileishmanial agents: Synthesis, in silico and in vitro evaluations.
Khatoon S; Aroosh A; Islam A; Kalsoom S; Ahmad F; Hameed S; Abbasi SW; Yasinzai M; Naseer MM
Bioorg Chem; 2021 May; 110():104816. PubMed ID: 33799180
[TBL] [Abstract][Full Text] [Related]
19. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of pyridinium-hydrazone derivatives as potential antitumoral agents.
Parlar S; Erzurumlu Y; Ilhan R; Ballar Kırmızıbayrak P; Alptüzün V; Erciyas E
Chem Biol Drug Des; 2018 Jul; 92(1):1198-1205. PubMed ID: 29415336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
